Donation After Circulatory Death in Pediatric Heart Transplantation

Sarah Dudley Grorud1, Michael D Porter2,3, Taufiek Konrad Rajab4

  • 1Pediatric Cardiology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.

Insights

Pediatric heart transplants using donation after circulatory death (DCD) organs offer more frequent offers and similar waitlist survival compared to donation after brain death (DBD) organs. This strategy expands access to donor hearts without impacting early outcomes.

Area of Science:

  • Pediatric Cardiology
  • Transplantation Immunology
  • Organ Donation

Background:

  • Donation after circulatory death (DCD) is an emerging strategy in heart transplantation (HT).
  • While successful in adults, pediatric DCD-HT is underutilized but gaining traction.
  • DCD offers potential to improve waitlist outcomes and expand donor pool.

Purpose of the Study:

  • To assess the impact of DCD listing on waitlist outcomes in pediatric heart transplantation.
  • To evaluate graft survival and offer dynamics for pediatric candidates listed for DCD versus DBD organs.
  • To determine if DCD listing affects waitlist mortality or post-transplant survival.

Main Methods:

  • Utilized the OPTN/UNOS database for pediatric primary isolated HT candidates (Jan 2021-June 2024).
  • Compared waitlist outcomes and offer dynamics based on DCD versus DBD listing.
  • Employed multivariable regression to model offer frequency and compared 30-day survival between DCD and DBD recipients.

Main Results:

  • DCD candidates (n=86) had higher clinical acuity than DBD candidates (n=2400).
  • DCD listing significantly increased offer rate by 134% and shortened intervals between offers.
  • Waitlist outcomes and 30-day post-transplant survival were similar between DCD and DBD groups.

Conclusions:

  • Pediatric DCD listing increases offer frequency and shortens offer intervals.
  • Waitlist survival is comparable despite higher acuity in DCD candidates.
  • Broader adoption of pediatric DCD-HT can expand donor heart access without compromising early outcomes.
Abstract